Heart muscle engineering: An update on cardiac muscle replacement therapy

Cardiovascular Research

Volumn 71, Issue 3, 2006, Pages 419-429

  Zimmermann, Wolfram Hubertus ^a   Didié, Michael ^a   Döker, Stephan ^a   Melnychenko, Ivan ^a   Naito, Hiroshi ^a   Rogge, Christina ^a   Tiburcy, Malte ^a   Eschenhagen, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cell therapy; Myocytes; Stem cells; Tissue engineering; Transplantation

Indexed keywords

COLLAGEN; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; INSULIN; MITOCHONDRIAL DNA; OXYGEN; PROTEIN KINASE B; SOMATOMEDIN C;

ANGIOGENESIS; BIOARTIFICIAL ORGAN; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; CELL SURVIVAL; CONGENITAL HEART MALFORMATION; ECONOMIC ASPECT; ELECTROPHYSIOLOGY; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; GENETIC ENGINEERING; GENETIC MANIPULATION; HEALTH CARE COST; HEALTH CARE SYSTEM; HEART FAILURE; HEART MUSCLE; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; HYPERBARIC OXYGEN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; IONTOPHORESIS; LEGAL ASPECT; LIVER PARENCHYMA; MOUSE STRAIN; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT STRAIN; REVIEW; RODENT; SOCIOECONOMICS; TISSUE ENGINEERING; TISSUE GRAFT; TISSUE STRUCTURE; TRANSGENE; TRANSGENICS; VASCULARIZATION;

ANIMALS; GRAFT REJECTION; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; MYOCARDIUM; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 33746301999     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.03.023     Document Type: Review

References (102)

1. Langer R., and Vacanti J.P. Tissue engineering. Science 260 (1993) 920-926
2. Wu F.J., Friend J.R., Remmel R.P., Cerra F.B., and Hu W.S. Enhanced cytochrome P450 IA1 activity of self-assembled rat hepatocyte spheroids. Cell Transplant 8 (1999) 233-246
3. Narushima M., Kobayashi N., Okitsu T., Tanaka Y., Li S.A., Chen Y., et al. A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol 23 (2005) 1274-1282
4. Shin'oka T., Matsumura G., Hibino N., Naito Y., Watanabe M., Konuma T., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 129 (2005) 1330-1338
5. Murry C.E., Field L.J., and Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 112 (2005) 3174-3183
6. Vesely I. Heart valve tissue engineering. Circ Res 97 (2005) 743-755
7. Isenberg B.C., Williams C., and Tranquillo R.T. Small-diameter artificial arteries engineered in vitro. Circ Res 98 (2006) 25-35
8. Zimmermann W.H., and Eschenhagen T. Cardiac tissue engineering for replacement therapy. Heart Fail Rev 8 (2003) 259-269
9. Eschenhagen T., and Zimmermann W.H. Engineering myocardial tissue. Circ Res 97 (2005) 1220-1231
10. Zimmermann W.H., Melnychenko I., and Eschenhagen T. Engineered heart tissue for regeneration of diseased hearts. Biomaterials 25 (2004) 1639-1647
11. Bursac N., Papadaki M., Cohen R.J., Schoen F.J., Eisenberg S.R., Carrier R., et al. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol 277 (1999) H433-H444
12. Kofidis T., Akhyari P., Boublik J., Theodorou P., Martin U., Ruhparwar A., et al. In vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg 124 (2002) 63-69
13. van Luyn M.J., Tio R.A., Gallego y van Seijen X.J., Plantinga J.A., de Leij L.F., DeJongste M.J., et al. Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures. Biomaterials 23 (2002) 4793-4801
14. Carrier R.L., Papadaki M., Rupnick M., Schoen F.J., Bursac N., Langer R., et al. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng 64 (1999) 580-589
15. Li R.K., Jia Z.Q., Weisel R.D., Mickle D.A., Choi A., and Yau T.M. Survival and function of bioengineered cardiac grafts. Circulation 100 (1999) II63-II69
16. Leor J., Aboulafia-Etzion S., Dar A., Shapiro L., Barbash I.M., Battler A., et al. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?. Circulation 102 (2000) III56-III61
17. Eschenhagen T., Fink C., Remmers U., Scholz H., Wattchow J., Weil J., et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J 11 (1997) 683-694
18. Zimmermann W.H., Fink C., Kralisch D., Remmers U., Weil J., and Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 68 (2000) 106-114
19. Zimmermann W.H., Schneiderbanger K., Schubert P., Didie M., Munzel F., Heubach J.F., et al. Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90 (2002) 223-230
20. Shimizu T., Yamato M., Isoi Y., Akutsu T., Setomaru T., Abe K., et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90 (2002) e40
21. Akins R.E., Boyce R.A., Madonna M.L., Schroedl N.A., Gonda S.R., and McLaughlin T.A. Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. Tissue Eng 5 (1999) 103-118
22. Moscona A.A. Tissues from dissociated cells. Sci Am 200 (1959) 132-134 [passim]
23. Hasenfuss G., Mulieri L.A., Blanchard E.M., Holubarsch C., Leavitt B.J., Ittleman F., et al. Energetics of isometric force development in control and volume-overload human myocardium. Comparison with animal species. Circ Res 68 (1991) 836-846
24. Wobus A.M., Wallukat G., and Hescheler J. Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 48 (1991) 173-182
25. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
26. Doetschman T.C., Eistetter H., Katz M., Schmidt W., and Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87 (1985) 27-45
27. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 100 (2003) 12313-12318
28. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108 (2001) 407-414
29. Mummery C., Ward-van Oostwaard D., Doevendans P., Spijker R., van den Brink S., Hassink R., et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107 (2003) 2733-2740
30. Laugwitz K.L., Moretti A., Lam J., Gruber P., Chen Y., Woodard S., et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433 (2005) 647-653
31. Xu C., Police S., Rao N., and Carpenter M.K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91 (2002) 501-508
32. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
33. Badorff C., Brandes R.P., Popp R., Rupp S., Urbich C., Aicher A., et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107 (2003) 1024-1032
34. Wu X., Ding S., Ding Q., Gray N.S., and Schultz P.G. Small molecules that induce cardiomyogenesis in embryonic stem cells. J Am Chem Soc 126 (2004) 1590-1591
35. Kawai T., Takahashi T., Esaki M., Ushikoshi H., Nagano S., Fujiwara H., et al. Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2. Circ J 68 (2004) 691-702
36. Jankowski M., Danalache B., Wang D., Bhat P., Hajjar F., Marcinkiewicz M., et al. Oxytocin in cardiac ontogeny. Proc Natl Acad Sci U S A 101 (2004) 13074-13079
37. Jackson K.A., Majka S.M., Wang H., Pocius J., Hartley C.J., Majesky M.W., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107 (2001) 1395-1402
38. Malouf N.N., Coleman W.B., Grisham J.W., Lininger R.A., Madden V.J., Sproul M., et al. Adult-derived stem cells from the liver become myocytes in the heart in vivo. Am J Pathol 158 (2001) 1929-1935
39. Urbanek K., Torella D., Sheikh F., De Angelis A., Nurzynska D., Silvestri F., et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A 102 (2005) 8692-8697
40. Linke A., Muller P., Nurzynska D., Casarsa C., Torella D., Nascimbene A., et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A 102 (2005) 8966-8971
41. Cai C.L., Liang X., Shi Y., Chu P.H., Pfaff S.L., Chen J., et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5 (2003) 877-889
42. Messina E., De Angelis L., Frati G., Morrone S., Chimenti S., Fiordaliso F., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95 (2004) 911-921
43. Nygren J.M., Jovinge S., Breitbach M., Sawen P., Roll W., Hescheler J., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10 (2004) 494-501
44. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
45. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., and Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
46. Laflamme M.A., and Murry C.E. Regenerating the heart. Nat Biotechnol 23 (2005) 845-856
47. Beltrami C.A., Finato N., Rocco M., Feruglio G.A., Puricelli C., Cigola E., et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89 (1994) 151-163
48. Gepstein L. Derivation and potential applications of human embryonic stem cells. Circ Res 91 (2002) 866-876
49. Wobus A.M., and Boheler K.R. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85 (2005) 635-678
50. Zandstra P.W., Bauwens C., Yin T., Liu Q., Schiller H., Zweigerdt R., et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng 9 (2003) 767-778
51. Pasumarthi K.B., and Field L.J. Cardiomyocyte cell cycle regulation. Circ Res 90 (2002) 1044-1054
52. Pasumarthi K.B., Nakajima H., Nakajima H.O., Soonpaa M.H., and Field L.J. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res 96 (2005) 110-118
53. Oh H., Taffet G.E., Youker K.A., Entman M.L., Overbeek P.A., Michael L.H., et al. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci U S A 98 (2001) 10308-10313
54. Engel F.B., Schebesta M., Duong M.T., Lu G., Ren S., Madwed J.B., et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 19 (2005) 1175-1187
55. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89 (1992) 5547-5551
56. Wang Y., Xu J., Pierson T., O'Malley B.W., and Tsai S.Y. Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator. Gene Ther 4 (1997) 432-441
57. Field L.J. Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science 239 (1988) 1029-1033
58. Claycomb W.C., Lanson Jr. N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 95 (1998) 2979-2984
59. Engel F.B., Hauck L., Cardoso M.C., Leonhardt H., Dietz R., and von Harsdorf R. A mammalian myocardial cell-free system to study cell cycle reentry in terminally differentiated cardiomyocytes. Circ Res 85 (1999) 294-301
60. Wicha M.S., Liu S., and Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res 66 (2006) 1883-1890
61. Kustikova O., Fehse B., Modlich U., Yang M., Dullmann J., Kamino K., et al. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308 (2005) 1171-1174
62. Schaub M.C., Hefti M.A., Harder B.A., and Eppenberger H.M. Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med 75 (1997) 901-920
63. Brutsaert D.L. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83 (2003) 59-115
64. Mohamed S.N., Holmes R., and Hartzell C.R. A serum-free, chemically-defined medium for function and growth of primary neonatal rat heart cell cultures. In Vitro 19 (1983) 471-478
65. Suzuki T., Ohta M., and Hoshi H. Serum-free, chemically defined medium to evaluate the direct effects of growth factors and inhibitors on proliferation and function of neonatal rat cardiac muscle cells in culture. In Vitro Cell Dev Biol 25 (1989) 601-606
66. Fujio Y., Nguyen T., Wencker D., Kitsis R.N., and Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101 (2000) 660-667
67. Matsui T., Li L., del Monte F., Fukui Y., Franke T.F., Hajjar R.J., et al. Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 100 (1999) 2373-2379
68. Naito H, Melnychenko I, Didie M, Schneiderbanger K, Schubert P, Jaser M, et al, Optimizing Engineered Heart Tissue for Therapeutic Applications as Surrogate Heart Muscle. Circulation in press.
69. Radisic M., Malda J., Epping E., Geng W., Langer R., and Vunjak-Novakovic G. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng 93 (2006) 332-343
70. Radisic M., Yang L., Boublik J., Cohen R.J., Langer R., Freed L.E., et al. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol 286 (2004) H507-H516
71. Zimmermann W.H., Melnychenko I., Wasmeier G.H., Didie M., Naito N., Nixdorff U., et al. Engineered Heart Tissue Grafts Improve Systolic and Diastolic Function in Infarcted Rat Hearts. Nat Med 12 (2006) 452-458
72. Fink C., Ergun S., Kralisch D., Remmers U., Weil J., and Eschenhagen T. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J 14 (2000) 669-679
73. Radisic M., Park H., Shing H., Consi T., Schoen F.J., Langer R., et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A 101 (2004) 18129-18134
74. Risau W., and Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 11 (1995) 73-91
75. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
76. Kofidis T., Lenz A., Boublik J., Akhyari P., Wachsmann B., Mueller-Stahl K., et al. Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials 24 (2003) 5009-5014
77. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
78. Levenberg S., Rouwkema J., Macdonald M., Garfein E.S., Kohane D.S., Darland D.C., et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 23 (2005) 879-884
79. Khmelewski E., Becker A., Meinertz T., and Ito W.D. Tissue resident cells play a dominant role in arteriogenesis and concomitant macrophage accumulation. Circ Res 95 (2004) E56-E64
80. Moldovan N.I., Goldschmidt-Clermont P.J., Parker-Thornburg J., Shapiro S.D., and Kolattukudy P.E. Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ Res 87 (2000) 378-384
81. Franke W.W., Borrmann C.M., Grund C., and Pieperhoff S. The area composita of adhering junctions connecting heart muscle cells of vertebrates: I. Molecular definition in intercalated disks of cardiomyocytes by immunoelectron microscopy of desmosomal proteins. Eur J Cell Biol 85 (2006) 69-82
82. Kostin S., Hein S., Bauer E.P., and Schaper J. Spatiotemporal development and distribution of intercellular junctions in adult rat cardiomyocytes in culture. Circ Res 85 (1999) 154-167
83. Kostetskii I., Li J., Xiong Y., Zhou R., Ferrari V.A., Patel V.V., et al. Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure. Circ Res 96 (2005) 346-354
84. Zimmermann W.H., Didie M., Wasmeier G.H., Nixdorff U., Hess A., Melnychenko I., et al. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 106 (2002) I151-I157
85. Shimizu T., Sekine H., Yang J., Isoi Y., Yamato M., Kikuchi A., et al. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J (2006)
86. Dhein S., Muller A., Gerwin R., and Klaus W. Comparative study on the proarrhythmic effects of some antiarrhythmic agents. Circulation 87 (1993) 617-630
87. Mironov SF, Vetter FJ, Pertsov AM. Fluorescence imaging of cardiac propagation: spectral properties and filtering of optical action potentials. Am J Physiol Heart Circ Physiol in press. doi:10.1152/ajpheart.01003.2005.
88. Ruiz-Meana M., Garcia-Dorado D., Hofstaetter B., Piper H.M., and Soler-Soler J. Propagation of cardiomyocyte hypercontracture by passage of Na(+) through gap junctions. Circ Res 85 (1999) 280-287
89. Rubart M. Two-photon microscopy of cells and tissue. Circ Res 95 (2004) 1154-1166
90. Rohr S., Kucera J.P., Fast V.G., and Kleber A.G. Paradoxical improvement of impulse conduction in cardiac tissue by partial cellular uncoupling. Science 275 (1997) 841-844
91. Rohr S., and Salzberg B.M. Characterization of impulse propagation at the microscopic level across geometrically defined expansions of excitable tissue: multiple site optical recording of transmembrane voltage (MSORTV) in patterned growth heart cell cultures. J Gen Physiol 104 (1994) 287-309
92. Fast V.G., and Kleber A.G. Role of wavefront curvature in propagation of cardiac impulse. Cardiovasc Res 33 (1997) 258-271
93. Eschenhagen T., Didie M., Munzel F., Schubert P., Schneiderbanger K., and Zimmermann W.H. 3D engineered heart tissue for replacement therapy. Basic Res Cardiol 97 Suppl 1 (2002) I146-I152
94. Wakayama T., Tabar V., Rodriguez I., Perry A.C., Studer L., and Mombaerts P. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 292 (2001) 740-743
95. Hubner K., Fuhrmann G., Christenson L.K., Kehler J., Reinbold R., De La Fuente R., et al. Derivation of oocytes from mouse embryonic stem cells. Science 300 (2003) 1251-1256
96. Humpherys D., Eggan K., Akutsu H., Hochedlinger K., Rideout III W.M., Biniszkiewicz D., et al. Epigenetic instability in ES cells and cloned mice. Science 293 (2001) 95-97
97. Kennedy D. Editorial retraction. Science 311 (2006) 335
98. *. Transpl Int 19 (2006) 54-66
99. Dor V., Sabatier M., Montiglio F., Civaia F., and DiDonato M. Endoventricular patch reconstruction of ischemic failing ventricle. a single center with 20 years experience. advantages of magnetic resonance imaging assessment. Heart Fail Rev 9 (2004) 269-286
100. Jacobs J.P., and Maruszewski B. Computerized outcomes analysis for congenital heart disease. Curr Opin Pediatr 17 (2005) 586-591
101. Emory Health Care. Heart Transplant Program. http://www.emoryhealthcare.org/departments/heart_transplant/patient_info/faqs.html 2006.
102. Krupnick A.S., Kreisel D., Engels F.H., Szeto W.Y., Plappert T., Popma S.H., et al. A novel small animal model of left ventricular tissue engineering. J Heart Lung Transplant 21 (2002) 233-243